What if cancer cells could be re-engineered to turn against their own kind?
A new study in Science Translational Medicine, led by researchers at Brigham and Women’s Hospital, leverages the power of gene editing to take a critical step toward using cancer cells to kill cancer. The team reports promising results in preclinical models across multiple types of cancer cells, establishing a potential roadmap toward clinical translation for treating primary, recurrent and metastatic cancer.
“This is just the tip of the iceberg,” said corresponding author Khalid Shah MS, PhD, director of the Center for Stem Cell Therapeutics and Imaging (CSTI) in the BWH Department of Neurosurgery and faculty at Harvard Medical School and Harvard Stem Cell Institute (HSCI). “Cell-based therapies hold tremendous promise for delivering therapeutic agents to tumors and may provide treatment options where standard therapy has failed. With our technique, we show it is possible to reverse-engineer a patient’s own cancer cells and use them to treat cancer. We think this has many implications and could be applicable across all cancer cell types.”
The new approach capitalizes on cancer cells’ self-homing ability – the process in which cancer cells can track the cells of their kind that have spread within the same organ or to other parts of the body. Harnessing this power could overcome drug delivery challenges, helping get therapeutics to tumor sites that may otherwise be difficult to reach.
The team developed and tested two techniques to harness the power of cancer cells. The “off the shelf” technique used pre-engineered tumor cells that would need to be matched to a patient’s HLA phenotype (essentially, a person’s immune fingerprint). The “autologous” approach used CRISPR technology to edit the genome of a patient’s cancer cells and insert therapeutic molecules. These cells could then be transferred back into the patient.
To test both approaches, the team used mouse models of primary and recurrent brain cancer and breast cancer that has spread to the brain. The team saw direct migration of engineered cells to the sites of tumors and found evidence that the engineered cells specifically targeted and killed recurrent and metastatic cancer in the mice. The researchers report that the treatment increased the survival of the mice. Engineered cells were equipped with a “kill switch” that could be activated after treatment – PET imaging showed that this kill switch worked to eliminate the cells.
“Our study demonstrates the therapeutic potential of using engineered tumor cells and their self-homing properties for developing receptor-targeted therapeutics for various cancers,” said Shah.
The Latest on: Engineered cancer cells
via Google News
The Latest on: Engineered cancer cells
- Researchers develop new platform that recreates cancer in a dish to quickly determine the best bacterial therapy on April 17, 2019 at 2:07 pm
Engineering bacteria to intelligently sense and respond to disease states, from infections to cancer ... to form a genetic circuit in which cells can be engineered to sense the environment ... […]
- CRISPR has been used to treat US cancer patients for the first time on April 17, 2019 at 6:16 am
Ex vivo: It’s safer and easier to employ the CRISPR technique on cells removed from a patient’s body. That’s the case in the new cancer study, in which doctors collected blood from patients and then ... […]
- ‘Reverse Engineered’ Brain Cancer Cells Useful for Identifying New Drug Targets on April 17, 2019 at 5:00 am
'Reverse engineering' of brain cancer cells is now possible using the latest technology This will help in the identification of new drug targets for dangerous cancers such as glioblastoma This will ... […]
- Cancer Treatment: ‘Reverse Engineered’ Brain Cancer Cells Uncover New Ways To Treat Condition on April 17, 2019 at 3:35 am
Glioblastoma, also known as GBM, is the most aggressive cancer that begins within the brain. It is one of the deadliest form of cancer because of the limited treatment options. A team of scientists ... […]
- Two Patients Treated with CRISPRed Cells in Immunotherapy Trial on April 16, 2019 at 2:30 pm
His team would filter T cells from the blood of eligible patients with cancer, then use the gene-editing technique to knock out three of the cells’ existing receptors and with a lentiviral vector ... […]
- Scientists 'reverse engineer' brain cancer cells to find new targets for treatment on April 16, 2019 at 8:27 am
It is also a leading cause of cancer-related death in children and young adults. Scientists have 'reverse engineered' brain cancer stem cells gene by gene, uncovering multiple potential targets for ... […]
- 'Nanobodies' from alpacas could help bring CAR T-cell therapy to solid tumors on April 14, 2019 at 10:57 am
Taking down melanoma and colon cancer Tested in two separate melanoma mouse models ... with no readily apparent side effects. Ploegh thinks that the engineered T cells work through a combination of ... […]
- UCSD patient gets first cancer treatment made from stem cells on April 13, 2019 at 6:30 pm
CAR T cells are genetically engineered to detect a specific molecular marker on the cancer cells. These cells have revolutionized cancer treatment, especially for blood cancers. Two approved ... […]
- Engineered T Cells Market: Report Provides Extensive Analysis of Various Trends and Prevailing Opportunities by 2023 on April 11, 2019 at 9:55 pm
and opportunities of the engineered T cells market. Factors such as increase in government expenditure for the healthcare sector, increased access to medical insurance, increase in geriatric ... […]
via Bing News